Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty

QR Code

Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Olusola A Orimoloye, Albert D Osei, SM Iftekhar Uddin, Mohammadhassan Mirbolouk, Michael J Blaha
Format:	article
Langue:	EN
Publié:	Radcliffe Medical Media 2019
Sujets:	Diseases of the circulatory (Cardiovascular) system RC666-701
Accès en ligne:	https://doaj.org/article/6b14f6740d964e1393c6c6d38ae15fc9
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Electronic Cigarettes and Cardiovascular Risk: Caution Waiting for Evidence
par: Domenico D’Amario, et autres
Publié: (2019)

ASPIRIN FOR CARDIOVASCULAR DISEASE PREVENTION AMONG ADULTS IN THE UNITED STATES: TRENDS, PREVALENCE, AND PARTICIPANT CHARACTERISTICS ASSOCIATED WITH USE
par: Ellen Boakye, et autres
Publié: (2021)

Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
par: Charles Amir German, et autres
Publié: (2020)

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
par: Mattia Cattaneo, et autres
Publié: (2019)

Cardiovascular Pharmacotherapy Focus
par: Pablo Avanzas
Publié: (2019)

Inflammation and Cardiovascular Disease: The Future
par: Natalie Arnold, et autres
Publié: (2021)

The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data
par: Hargun Kaur, et autres
Publié: (2021)

Hypertension in Africa: Redressing the burden of cardiovascular disease using cost-effective nonpharmacological approaches
par: Gavin R. Norton, et autres
Publié: (2017)

A hidden menace: Cardiovascular disease in South Africa and the costs of an inadequate policy response
par: Mandy Maredza, et autres
Publié: (2017)

Meditation and Cardiovascular Health: What is the Link?
par: Sebastian Schnaubelt, et autres
Publié: (2019)

COVID-19 Pandemic and Cardiovascular Disease
par: Aniket S Rali, et autres
Publié: (2020)

Deciphering the Riddles in Nutrition and Cardiovascular Disease
par: Amelia Carro, et autres
Publié: (2019)

The Association Between Psoriasis and Cardiovascular Diseases
par: Ahmed Zwain, et autres
Publié: (2021)

Effects of aerospace environments on the cardiovascular system
par: Erdinç Ercan
Publié: (2021)

Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior Preeclampsia/HELLP Syndrome: A Narrative Review
par: Esmee ME Bovee, et autres
Publié: (2021)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
par: Alberto J Lorenzatti, et autres
Publié: (2020)

Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
par: Aniket S Rali, et autres
Publié: (2021)

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
par: Aarti Thakkar, et autres
Publié: (2021)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
par: Chris Wai Hang Lo, et autres
Publié: (2021)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
par: Maki Komiyama, et autres
Publié: (2021)

The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
par: Pensée Wu, et autres
Publié: (2021)

New opportunities for reducing cardiovascular risk in the Russian Federation
par: O. D. Ostroumova, et autres
Publié: (2020)

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence
par: Koji Hasegawa, et autres
Publié: (2019)

Non-invasive Low-level Tragus Stimulation in Cardiovascular Diseases
par: Yunqiu Jiang, et autres
Publié: (2020)

Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
par: Alberto J Lorenzatti
Publié: (2021)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
par: Rhian M. Touyz, MBBCh, PhD, et autres
Publié: (2021)

COVID-19: a patient with cardiovascular disease at high risk
par: Irina E. Chazova, et autres
Publié: (2020)

Trending cardiac biomarkers during pregnancy in women with cardiovascular disease
par: Soohyun Chang, et autres
Publié: (2021)

Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
par: Nikita Lomakin, et autres
Publié: (2019)

24th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy
par: Hector Ventura
Publié: (2020)

Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?
par: Gianluigi Savarese
Publié: (2019)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
par: Anne Mirjam Kerola, et autres
Publié: (2021)

Implantable Cardiac Electronic Devices in the Elderly Population
par: Wei-Yao Lim, et autres
Publié: (2019)

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
par: Ernest Spitzer, et autres
Publié: (2020)

Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
par: BMY Cheung, et autres
Publié: (2020)

Excess mortality in Greece during 2020: the role of COVID-19 and cardiovascular disease
par: Demosthenes Panagiotakos, et autres
Publié: (2021)

Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women
par: Per Eriksson, et autres
Publié: (2021)

Cardiovascular health and risk of hospitalization with COVID-19: A Mendelian Randomization study
par: Marina Cecelja, et autres
Publié: (2021)

Posters from the 24th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy
par: BMY Cheung, et autres
Publié: (2020)

Recommendations for Ramadan fasting to patients with cardiovascular diseases; Turkish Society of Cardiology consensus report
par: Ahmet Taha Alper, et autres
Publié: (2021)